Therapy of acquired immune deficiency syndrome with recombinant interleukin-2.

Recombinant human interleukin-2 (rIL-2) was administered to 87 patients with the acquired immune deficiency syndrome (AIDS) to test the hypothesis that this lymphokine would correct the underlying qualitative and quantitative deficiency in cellular immunity. Patients were divided into two groups by the presence or absence of Kaposi's sarcoma and subjects… (More)

Topics

Statistics

0102030'94'97'00'03'06'09'12'15'18
Citations per Year

71 Citations

Semantic Scholar estimates that this publication has 71 citations based on the available data.

See our FAQ for additional information.